Can the patient who received a ketorolac (Toradol) injection today be continued on oral ketorolac (Toradol) and what is the appropriate dosing?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Ketorolac (Toradol) Be Continued Orally After Injection?

Yes, you can continue the patient on oral ketorolac after an injection today, but only for a maximum combined duration of 5 days total (injection + oral), with oral dosing of 10 mg every 4-6 hours (maximum 40 mg/day) for most adults. 1

Critical Dosing Guidelines

The FDA label is explicit about oral ketorolac use 1:

Transition Dosing (Following IV/IM Injection)

For patients age 17-64 years:

  • 20 mg PO once as the first oral dose
  • Then 10 mg every 4-6 hours as needed
  • Maximum 40 mg/day

For patients ≥65 years, renally impaired, or weight <50 kg (110 lbs):

  • 10 mg PO once as the first oral dose
  • Then 10 mg every 4-6 hours as needed
  • Maximum 40 mg/day

Absolute Duration Limit

The combined duration of IV/IM ketorolac plus oral ketorolac must not exceed 5 days. 1, 2 This is a hard stop due to increased risk of serious adverse events including GI bleeding, renal toxicity, and cardiovascular complications with longer use 3, 4.

Important Contraindications and Cautions

Before prescribing oral continuation, verify the patient does NOT have 3, 4:

  • Age ≥60 years (higher risk for GI/renal toxicity)
  • History of peptic ulcer disease or GI bleeding
  • Renal impairment (adjust dose as above)
  • Cardiovascular disease or risk factors
  • Concurrent anticoagulation (warfarin, heparin)
  • Bleeding disorders or thrombocytopenia
  • Aspirin/NSAID-induced asthma
  • Significant alcohol use (≥2 drinks/day)

Clinical Context

Multiple guidelines emphasize ketorolac should be short-term only 3. The 2010 NCCN cancer pain guidelines specifically state: "consider short-term use of ketorolac; 15-30 mg IV, every 6 hours for maximum of 5 days" 3. The 2024 ICU pain management guidelines note ketorolac's pros include direct anti-inflammatory effects but cons include "reduced doses with renal dysfunction, increased risk of bleeding with peptic ulcer disorder, increased risk in older age" 4.

Recent evidence suggests lower doses may be equally effective. A 2023 systematic review found that 15-20 mg doses were probably as effective as 30+ mg doses for acute pain, with potentially fewer adverse events 5. A 2021 military ED study demonstrated 15 mg IM was non-inferior to 60 mg for musculoskeletal pain 6.

Common Pitfalls to Avoid

  1. Do not exceed 5 days total duration - This includes the injection day. If the patient received an injection today, oral therapy can continue for only 4 more days maximum.

  2. Do not use oral ketorolac as initial therapy - FDA labeling explicitly states oral formulation should not be given as an initial dose; it's continuation therapy only 1.

  3. Do not shorten the dosing interval below 4-6 hours, even if pain persists 1.

  4. Do not assume younger patients can take higher total daily doses - The 40 mg/day maximum applies to all adults under 65 years 1.

  5. Monitor for toxicity - Even short-term use requires vigilance for GI upset, hypertension, edema, or changes in renal function 3, 4.

When to Choose Alternative Analgesia

Consider switching to other NSAIDs (ibuprofen 400-800 mg every 6 hours) or acetaminophen if 7, 8:

  • Pain is expected to last beyond 5 days
  • Patient has multiple risk factors for NSAID toxicity
  • Patient develops adverse effects (nausea, GI upset, edema, hypertension)

The 2020 ACEP opioid policy notes that for acute pain conditions, NSAIDs like ibuprofen or naproxen are often as effective as opioids with fewer adverse effects 7. Multimodal analgesia combining acetaminophen with NSAIDs is recommended when possible 8.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.